SAM
NVCR icon

Smartleaf Asset Management’s NovoCure NVCR Stock Holding History

Smartleaf Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.23K Sell
408
-67
-14% -$837 ﹤0.01% 2732
2025
Q4 		$6.28K Buy
475
+268
+129% +$3.44K ﹤0.01% 2609
2025
Q3 		$2.67K Buy
207
+178
+614% +$2.38K ﹤0.01% 2537
2025
Q2 		$522 Sell
29
-224
-89% -$3.9K ﹤0.01% 2580
2025
Q1 		$4.77K Buy
253
+69
+38% +$1.57K ﹤0.01% 2202
2024
Q4 		$5.53K Sell
184
-155
-46% -$3.28K ﹤0.01% 2214
2024
Q3 		$5.29K Buy
339
+252
+290% +$4.57K ﹤0.01% 2094
2024
Q2 		$1.53K Buy
87
+36
+71% +$633 ﹤0.01% 2314
2024
Q1 		$746 Buy
+51
New +$750 ﹤0.01% 1675

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Smartleaf Asset Management's NVCR Position: Q1 2026 in Review

Smartleaf Asset Management reduced its NovoCure (NVCR) stake by 14% in Q1 2026, selling an estimated $837 and leaving 408 shares worth $4.23K. The position accounts for ﹤0.01% of the portfolio, ranked #2732.

Smartleaf Asset Management first reported a position in NVCR in Q1 2024 and has held it in 9 quarters since. The position peaked at $6.28K in Q4 2025. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Smartleaf Asset Management held 408 shares of NovoCure worth $4.23K as of Q1 2026.
  • Smartleaf Asset Management sold 67 NovoCure shares in Q1 2026, an estimated $837.
  • NovoCure made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2732 holding.
  • Smartleaf Asset Management first reported a position in NovoCure in Q1 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's NovoCure position peaked at $6.28K in Q4 2025.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.